Stem cell treatment for Parkinson’s disease
Seoul, February 20, 2014
South Korea’s Stem cell research institute has claimed stem cell therapy success for patients with Parkinson’s disease, a chronic progressive degenerative disease in nervous system.
It said STC Life Co and 97.7 B&H Clinic have successfully conducted the stem cell therapy.
Parkinson’s disease is caused when dopamine nerve cells distributed in substance nigra become gradually extinct. It is a chronic progressive degenerative disease characteristically showing quiver, stiffness, bradykinesia and postural instability. General medicine treatment has no effect on Parkinson’s disease and there are no other treatments for it.
The statement said 97.7 B&H Clinic administered stem cell into vein of the patients with Parkinson’s disease three times every two weeks. Mesenchymal stem cell, one of the adult stem cells, is used a lot for neogenesis, and stem cell research institute of STC Life used stem cells separated from umbilical cord of fetus.
The patients who got stem cell therapy showed remarkable reduction of the symptoms such as lalopathy and paralysis of arms and legs and also showed satisfactory progress to be able to do light exercise, it said. Furthermore, their linguistic ability, visual function and memory increased and they have not shown remarkable deterioration in cognitive function, it said.
“It is proven that Mesenchymal stem cell therapy can reduce the symptoms with no adverse effects,” the statement said. – TradeArabia News Service